PAH Clinical Scenarios: Advances in Diagnostic Assessment, Guideline-Recommended Care, and Emerging Treatments

Target Audience
This educational activity is designed for pulmonologists and cardiologists, primarily, as well as physicians in internal medicine, primary care, and family medicine, physician assistants, nurse practitioners, and other healthcare providers who may be involved in managing care for patients with pulmonary arterial hypertension (PAH).

Program Overview
PAH is a rare, life-threatening disorder characterized by elevated pressure in the pulmonary arteries that quickly progresses to right ventricular failure and premature death. Expert consensus recommends early diagnosis and immediate treatment to improve survival in this mostly younger adult patient population. However, because PAH is an orphan disease with nonspecific presenting symptoms such as dyspnea, fatigue, weakness, heart palpitations, edema, and/or syncope, diagnosis is a challenge. In addition to knowing how to recognize and diagnose PAH, physicians must also be able initiate appropriate therapeutic strategies, generally combination therapies using multiple drug classes, and be aware of emerging treatment modalities to optimize outcomes.

Join experts Dr. John Ryan and Dr. Vallerie McLaughlin for this interactive on-demand video presentation about diagnosing, assessing, and managing PAH with optimal combination strategies of currently available and emerging treatments.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe the signs and symptoms of PAH
Identify assessment tools used to aid in the diagnosis and prognosis of PAH
Incorporate guideline-recommended care for patients with PAH considerate of current and recently approved therapeutic options
Evaluate the efficacy and safety of emerging therapeutic options for PAH